michael r ladomery
University of the West of England
Bristol, United Kingdom
Associate Editor
Cancer Genetics and Oncogenomics
University of the West of England
Bristol, United Kingdom
Associate Editor
Cancer Genetics and Oncogenomics
Dankook University
Yongin, Republic of Korea
Associate Editor
Cancer Genetics and Oncogenomics
The First Affiliated Hospital of Soochow University
Suzhou, China
Associate Editor
Cancer Genetics and Oncogenomics
Moscow Institute of Physics and Technology
Dolgoprudny, Russia
Associate Editor
Cancer Genetics and Oncogenomics
Nencki Institute of Experimental Biology, Polish Academy of Sciences
Warszawa, Poland
Associate Editor
Cancer Genetics and Oncogenomics
Houston Methodist Research Institute
Houston, United States
Associate Editor
Cancer Genetics and Oncogenomics
University of Liverpool
Liverpool, United Kingdom
Associate Editor
Cancer Genetics and Oncogenomics
University College London
London, United Kingdom
Associate Editor
Cancer Genetics and Oncogenomics
Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences (CAS)
Tianjin, China
Associate Editor
Cancer Genetics and Oncogenomics
Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, G. Pascale National Cancer Institute Foundation (IRCCS)
Naples, Italy
Associate Editor
Cancer Genetics and Oncogenomics
University of Alabama at Birmingham
Birmingham, United States
Associate Editor
Cancer Genetics and Oncogenomics
Icahn School of Medicine at Mount Sinai
New York, United States
Associate Editor
Cancer Genetics and Oncogenomics
University of Tabuk
Tabuk, Saudi Arabia
Associate Editor
Cancer Genetics and Oncogenomics
Memorial Sloan Kettering Cancer Center
New York, United States
Associate Editor
Cancer Genetics and Oncogenomics
HĂ´pital ophtalmique Jules-Gonin
Lausanne, Switzerland
Associate Editor
Cancer Genetics and Oncogenomics
University of North Dakota
Grand Forks, United States
Associate Editor
Cancer Genetics and Oncogenomics